Influenza Vaccine Hesitancy and Its Determinants Among Rheumatology Patients.

ABSTRACT:

Objective

Patients with rheumatic disease (RD) have an increased risk of influenza and its complications. Despite inactivated influenza vaccine (IIV) recommendations, IIV uptake in patients with RD is suboptimal, a problem of increasing importance in the COVID-19 era. We estimated the frequency of IIV hesitancy and associated factors among Canadian patients with RD.

Methods

A cross-sectional vaccine hesitancy survey was completed by rheumatology clinic patients (November 2019 to January 2020). Patients rated their likelihood of receiving the influenza vaccine (scale of 0-10). We categorized these as follows: likely to refuse (scale of 0-2), uncertain (scale of 3-7), or likely to accept (scale of 8-10). Multivariate logistical regression was used to evaluate factors associate

SUBMITTER: Valerio V 

PROVIDER: S-EPMC8992470 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature